In Australia
Strides Arcolab announced that Strides Pharma Global, Singapore and Strides (Australia) Pharma, Australia, both subsidiaries of Strides Arcolab have signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings, a company listed on the Johannesburg Stock Exhchange (Aspen), to acquire a generic pharmaceutical business in Australia together with certain branded pharmaceutical assets. The transaction is expected to close by the end of Q2 FY 2016. The consideration of the acquisition will be approximately A$380 million.Powered by Capital Market - Live News
